PUOTI MASSIMO

Ruolo:
Professore straordinario a tempo determinato
Settore scientifico disciplinare:
Malattie infettive (MEDS-10/B)
Gruppo scientifico disciplinare:
GASTROENTEROLOGIA, MALATTIE INFETTIVE E MALATTIE CUTANEE (06/MEDS-10)
Telefono:

Pubblicazioni

  • D'Arminio Monforte, A., Lentini, N., Tavelli, A., Rusconi, S., Sozio, F., Guida, A., et al. (2026). Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500 000 copies/mL in 2018–2023 in Italy: data from the ICONA Foundation Cohort Study. CLINICAL MICROBIOLOGY AND INFECTION [10.1016/j.cmi.2026.01.007]. Dettaglio

  • Micheli, G., Mondi, A., Roen, A., Taramasso, L., Luchetti, I., Mazzotta, V., et al. (2026). Did the COVID-19 pandemic shift the landscape of late HIV diagnosis?. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 165(April 2026) [10.1016/j.ijid.2026.108437]. Dettaglio

  • Gagliardini, R., De Benedittis, S., Tavelli, A., Lapadula, G., Mazzotta, V., Bruzzesi, E., et al. (2025). Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(8), 2169-2178 [10.1093/jac/dkaf184]. Dettaglio

  • Mussini, C., Giacomelli, A., Quiros-Roldan, E., Mazzotta, V., Di Biagio, A., De Vito, A., et al. (2025). Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation. ECLINICALMEDICINE, 86(August 2025) [10.1016/j.eclinm.2025.103368]. Dettaglio

  • Iavarone, M., Alimenti, E., Puoti, M., Hasson, H., Monti, B., Bhoori, S., et al. (2025). Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study. LIVER INTERNATIONAL, 45(12) [10.1111/liv.70437]. Dettaglio